Incyte INCY
NASDAQ INCY
$122.27 +1.97 (+1.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Incyte (INCY) Income from Continuing Operations (2009 - 2026)

Updated

Incyte's Income from Continuing Operations was -$784.8 million in Q3 2026, compared with $424.17 million a year earlier.

Analysis

Incyte (INCY) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Incyte's Income from Continuing Operations was $403.41 million through Sep 30, 2026, down 66.1% year-over-year; for FY2025, it came in at $1.29 billion.

  • In earlier years, Income from Continuing Operations was $32.62 million in FY2024 (-94.5%), $597.6 million in FY2023 (+75.4%), $340.66 million in FY2022 (-64.1%) and $948.58 million in FY2021.
  • The Q3 2026 figure marks the lowest quarterly Income from Continuing Operations in data going back to Q1 2010.
  • Compared with a year earlier, Income from Continuing Operations was higher in five of the last six quarters, with growth averaging 79.5%.
  • The best year-over-year quarter for Income from Continuing Operations over five years was Q1 2024 (growth of 681.2%); the worst was Q4 2022 (a decline of 95.0%).
  • Per Business Quant data, INCY's Income from Continuing Operations in the three quarters before Q3 2026 was $585.61 million (Q2 2026), $303.33 million (Q1 2026) and $299.28 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 Incyte 245.42 Mn -15.74 Bn 1.45 Bn -784.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -784.80 Mn
Jun 30, 2026 585.61 Mn
Mar 31, 2026 303.33 Mn
Dec 31, 2025 299.28 Mn
Sep 30, 2025 424.17 Mn
Jun 30, 2025 405.00 Mn
Mar 31, 2025 158.20 Mn
Dec 31, 2024 201.21 Mn
Sep 30, 2024 106.46 Mn
Jun 30, 2024 -444.60 Mn
Mar 31, 2024 169.55 Mn
Dec 31, 2023 201.08 Mn
Sep 30, 2023 171.27 Mn
Jun 30, 2023 203.55 Mn
Mar 31, 2023 21.70 Mn
Dec 31, 2022 28.46 Mn
Sep 30, 2022 112.78 Mn
Jun 30, 2022 161.43 Mn
Mar 31, 2022 37.99 Mn
Dec 31, 2021 563.86 Mn
API Access

Incyte Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INCY&period=max&api_key=YOUR_API_KEY